TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Q: What does CUSIP 881624209 represent in this 13F holders report?

CUSIP 881624209 is the security identifier for TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in Q2 2020?

435 institutional investors reported TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 881624209

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Ordinary Shares, par value NIS 0.01 per share
Total 13F shares: 578,768,724
Total 13F value: $7,127,077,578
Share change: +24,268,717
Put/Call ratio: 97%
SEC-reported price per share: $12.33
Number of holders: 435
Value change: +$321,923,360
Number of buys: 177
Number of sells: 194
Shares outstanding: 1,148,777,709

Security key

881624209

Report period

Q2 2020

Institutions

435

Top holders

TEVA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2020 Previous quarter: Q1 2020 TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings TEVA PHARMACEUTICAL INDUSTRIES LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 881624209

Newer quarter: Q3 2020 Previous quarter: Q1 2020

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Capital Research Global I...

Disclosed value leader

Capital Research Global I...

Comparable rows

15/15

Latest evidence

31 Mar 2020

13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.

Comparable ownership Top 5

Capital Research Global Investors 11%

BERKSHIRE HATHAWAY INC 3.7%

BlackRock Finance, Inc. 3.3%

Capital World Investors 2.9%

ABRAMS CAPITAL MANAGEMENT, L.P. 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	11%	$1,168,200,000 130,090,801 shares	—	31 Mar 2020
BERKSHIRE HATHAWAY INC	13F Company 13F	3.7%	$384,248,000 42,789,295 shares	—	31 Mar 2020
BlackRock Finance, Inc.	13F Company 13F	3.3%	$338,871,000 37,736,307 shares	—	31 Mar 2020
Capital World Investors	13F Company 13F	2.9%	$297,114,000 33,086,826 shares	—	31 Mar 2020
ABRAMS CAPITAL MANAGEMENT, L.P.	13F Company 13F	2.1%	$215,936,000 24,046,356 shares	—	31 Mar 2020
Migdal Insurance & Financial Holdings Ltd.	13F Company 13F	1.9%	$197,299,000 21,970,954 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

435

578,768,724

Rows available

435

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

430

Q2 2020 holders

435

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend